Rhinocerebral mucormycosis in a patient with AIDS: a complication of diabetic ketoacidosis following pentamidine therapy.

@article{Abril1996RhinocerebralMI,
  title={Rhinocerebral mucormycosis in a patient with AIDS: a complication of diabetic ketoacidosis following pentamidine therapy.},
  author={Vicente Andr{\'e}s Abril and Enrique Ortega and Pilar Segarra and Francesc Pedr{\'o} and Vicente Sabater and Alberto Naranjo Herrera},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={1996},
  volume={23 4},
  pages={845-6}
}
Figure 1. Total WBC count (0) and ANC (e) for patient 1, a 37year-old male who developed vancomycin-induced neutropenia. G-CSF (600 f.Lg iv) was initially administered on days 30 and 33 of therapy. Additional 300-f.Lg doses of iv G-CSF were administered twice weekly (on days 38-52) and thrice weekly (on days 55-78) until vancomycin therapy was completed. ANC = absolute neutrophil count. 8,500 

References

Publications referenced by this paper.
Showing 1-10 of 12 references

Agents of mucormycosis and related species

  • AN Sugar
  • 1995

High incidence of vancomycin - associated leukopenia and neutropenia in a cardiothoracic surgical unit

  • AH Teitelbaum, AJ Bell, SL Brown
  • J Infect
  • 1991

Case report : prolonged vancomycin - associated neutropenia in a chronic hemodialysis patient

  • HG Dangerfield, WL Hewitt, OT Monzon, Z Kudinoff, B Blaukrnan, SM Finegold
  • Am J Med Sci
  • 1987

Retrospective study of the toxicity of prep a - ration of vancomycin from 1974 to 1981

  • A Morris, C Ward
  • Antimicrob Agents Chemother
  • 1983

Neutropenia associated with vancomycin therapy

  • BC West
  • South Med J
  • 1982

Similar Papers

Loading similar papers…